13 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 13 of 13 clinical reviews.
A comprehensive, evidence-graded guide to cardiovascular prevention in 2026: when to treat, which medications work, how to compare options, and who should avoid each therapy. Written by the HealthRX.com medical team and reviewed by board-certified physicians.
A comprehensive, evidence-graded guide to erectile dysfunction covering diagnosis, all treatment options, head-to-head comparisons, who shouldn't use each therapy, and monitoring protocols prepared by the HealthRX.com Editorial Team.
Finasteride, minoxidil, spironolactone and dutasteride compared by trial data, with dosing, who should avoid each drug, and monitoring schedules.
Evidence-based guide to hormone replacement therapy (HRT) covering estrogen, progesterone, testosterone, delivery methods, risks, monitoring, and treatment selection for menopause and hypogonadism.
A guide to every longevity medication with real clinical trial data, evidence grades, dosing ranges, and monitoring requirements. Learn which interventions have the strongest support and who should consider them.
A comprehensive, evidence-based guide to menopause treatment options in 2026, including hormone therapy, non-hormonal medications, lifestyle strategies, and how to choose the right approach for your symptoms and health history.
Evidence-based guide to osteoporosis diagnosis, medications, monitoring, and prevention. Covers bisphosphonates, denosumab, romosozumab, teriparatide, and lifestyle interventions with trial data and dosing details.
A guide to every major prescription option for men over 40, covering testosterone replacement, GLP-1 weight-loss agents, cardiovascular medications, erectile dysfunction drugs, and more, with evidence grades, dosing ranges, and monitoring protocols.
A comprehensive, evidence-graded guide to prescription medications in pregnancy, covering safety classifications, trimester-specific risks, treatment comparisons, and monitoring protocols prepared by the HealthRX.com Editorial Team.
Rexulti lactation data is limited, with Hale risk category and milk transfer factors explained so you can review options with a lactation-trained clinician.
A guide to therapeutic peptides in 2026: what they are, how they work, which uses have FDA approval and randomized-trial support versus animal or early-phase data only, safety concerns, and what to ask before starting one.
Evidence-based guide to type 2 diabetes treatments in 2026, covering metformin, GLP-1 receptor agonists, SGLT2 inhibitors, insulin, and emerging therapies with head-to-head comparisons and monitoring protocols.
Compare FDA-approved weight loss medications by results: tirzepatide up to 22.5%, semaglutide 14.9%. See BMI eligibility and how to choose with your doctor.